CSIMarket
 


Zimmer Biomet Holdings Inc   (ZBH)
Other Ticker:  
 
 

ZBH's Free Cash Flow Growth by Quarter and Year

Zimmer Biomet Holdings Inc 's Free Cash Flow results by quarter and year




ZBH Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 244.20 365.70 425.10
III Quarter September 337.60 450.80 433.10 381.30
II Quarter June 347.90 345.50 453.90 -52.80
I Quarter March 307.70 315.70 246.50 450.90
FY   993.20 1,356.20 1,499.20 1,204.50



ZBH Free Cash Flow third quarter 2023 Y/Y Growth Comment
Zimmer Biomet Holdings Inc reported fall in Free Cash Flow in the third quarter 2023 by -25.11% to $ 337.60 millions, from the same quarter in 2022.
The drop in the third quarter 2023 Zimmer Biomet Holdings Inc 's Free Cash Flow compares unfavorably to the Company's average Free Cash Flow increase of 14.87%.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 30 other companies have achieved higher Free Cash Flow growth. While Zimmer Biomet Holdings Inc ' s Free Cash Flow drop of -25.11% ranks overall at the positon no. 1057 in the third quarter 2023.




ZBH Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -33.22 % -13.97 % 0.43 %
III Quarter September -25.11 % 4.09 % 13.59 % -34.02 %
II Quarter June 0.69 % -23.88 % - -
I Quarter March -2.53 % 28.07 % -45.33 % 58.99 %
FY   - -9.54 % 24.47 % -24.04 %

Financial Statements
Zimmer Biomet Holdings Inc 's third quarter 2023 Free Cash Flow $ 337.60 millions ZBH's Income Statement
Zimmer Biomet Holdings Inc 's third quarter 2022 Free Cash Flow $ 450.80 millions Quarterly ZBH's Income Statement
New: More ZBH's historic Free Cash Flow Growth >>


ZBH Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -45.83 % -15.56 % 11.49 %
III Quarter September -2.96 % 30.48 % -4.58 % -
II Quarter June 13.06 % 9.44 % 84.14 % -
I Quarter March 26 % -13.67 % -42.01 % 6.52 %
FY (Year on Year)   - -9.54 % 24.47 % -24.04 %




Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #31
Healthcare Sector #85
Overall #1057

Free Cash Flow Y/Y Growth Statistics
High Average Low
369.07 % 14.87 % -48.84 %
(Jun 30 2017)   (Mar 31 2021)
Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #31
Healthcare Sector #85
Overall #1057
Free Cash Flow Y/Y Growth Statistics
High Average Low
369.07 % 14.87 % -48.84 %
(Jun 30 2017)   (Mar 31 2021)

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Zimmer Biomet Holdings Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
111.75 % 7.07 % -56.09 %
(Dec 31 2016)  


ZBH's III. Quarter Q/Q Free Cash Flow Comment
In the III. Quarter 2023 Zimmer Biomet Holdings Inc realized fall in Free Cash Flow from the previous quarter by -2.96% to $ 337.60 millions, from $ 347.90 millions released in the previous quarter.

Those seasonal influence have not salvage the III. Quarter for the Zimmer Biomet Holdings Inc , Amanda N. Lee, an industry insider pointed out and mentioned that average sequential Free Cash Flow growth is at 7.07% for Zimmer Biomet Holdings Inc .

Within Medical Equipment & Supplies industry 35 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Zimmer Biomet Holdings Inc 's Free Cash Flow growth quarter on quarter, overall rank is 1013.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #36
Healthcare Sector #88
Overall #1013
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #36
Healthcare Sector #88
Overall #1013
Free Cash Flow Q/Q Growth Statistics
High Average Low
111.75 % 7.07 % -56.09 %
(Dec 31 2016)  


ZBH's III. Quarter Q/Q Free Cash Flow Comment
In the III. Quarter 2023 Zimmer Biomet Holdings Inc reported fall in Free Cash Flow from the second quarter by -2.96% to $ 337.60 millions, from $ 347.90 millions declared in the previous reporting period.

Those seasonal circumstance have not rescue the III. Quarter for the Zimmer Biomet Holdings Inc , Amanda N. Lee, an industry insider wrote, she identified additional headwinds onward for the Medical Equipment & Supplies's company and wrote that average quarter on quarter Free Cash Flow growth is at 7.07% for the Medical Equipment & Supplies's company.

Within Medical Equipment & Supplies industry 35 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Zimmer Biomet Holdings Inc 's Free Cash Flow growth quarter on quarter, overall rank is 1013.


Zimmer Biomet Holdings Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Free Cash Flow 12 Months Ending $ 1,615.50 $ 1,678.50 $ 1,546.40 $ 1,544.10 $ 1,673.70
Y / Y Free Cash Flow Growth (TTM) -3.48 % 0.93 % -12.03 % -8.07 % -1.29 %
Year on Year Free Cash Flow Growth Overall Ranking # 1079 # 1150 # 248 # 576 # 865
Seqeuential Free Cash Flow Change (TTM) -3.75 % 8.54 % 0.15 % -7.74 % 0.64 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 1057 # 1313 # 566 # 1007 # 902




Cumulative Free Cash Flow growth Comment
For the 12 months ended Sep 30 2023 Zimmer Biomet Holdings Inc reported a decrease in Free Cash Flow by -3.48% year on year, to $1,616 millions, compare to the 0.93% growth at Jun 30 2023.

In the Healthcare sector 86 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 1079, from total ranking in previous quarter at 1150.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
369.07 %
14.87 %
-48.84 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 31
Healthcare Sector # 87
Overall # 1079

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
369.07 %
14.87 %
-48.84 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 31
Sector # 85
S&P 500 # 1057
Cumulative Free Cash Flow growth Comment
For the 12 months ended Sep 30 2023 Zimmer Biomet Holdings Inc reported a decrease in Free Cash Flow by -3.48% year on year, to $1,616 millions, compare to the 0.93% growth at Jun 30 2023.

In the Healthcare sector 86 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 1079, from total ranking in previous quarter at 1150.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
369.07 %
14.87 %
-48.84 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 31
Healthcare Sector # 87
Overall # 1079

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
369.07 %
14.87 %
-48.84 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 31
Sector # 85
S&P 500 # 1057




Other Free Cash Flow Growth
Medical Equipment & Supplies Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
ZBH's Free Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for ZBH's Competitors
Free Cash Flow Growth for Zimmer Biomet Holdings Inc 's Suppliers
Free Cash Flow Growth for ZBH's Customers

You may also want to know
ZBH's Annual Growth Rates ZBH's Profitability Ratios ZBH's Asset Turnover Ratio ZBH's Dividend Growth
ZBH's Roe ZBH's Valuation Ratios ZBH's Financial Strength Ratios ZBH's Dividend Payout Ratio
ZBH's Roa ZBH's Inventory Turnover Ratio ZBH's Growth Rates ZBH's Dividend Comparisons



Companies with similar Free Cash Flow decrease for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2023
Abbvie Inc -0.37%$ -0.368 millions
Insulet Corporation-1.23%$ -1.235 millions
National Research Corporation-2.32%$ -2.318 millions
Fonar Corporation-2.93%$ -2.929 millions
Viatris Inc -4.02%$ -4.016 millions
Pediatrix Medical Group Inc -4.07%$ -4.071 millions
Repligen Corp-5.16%$ -5.164 millions
Davita Inc -6.95%$ -6.948 millions
Amgen Inc -7.32%$ -7.320 millions
Adapthealth Corp -7.65%$ -7.653 millions
Dexcom Inc -8.19%$ -8.186 millions
Biogen Inc -10.38%$ -10.378 millions
Avantor Inc -10.69%$ -10.685 millions
Amneal Pharmaceuticals Inc -13.02%$ -13.020 millions
Biomarin Pharmaceutical Inc-14.32%$ -14.322 millions
Organon and Co -17.67%$ -17.666 millions
Hca Healthcare Inc -17.91%$ -17.914 millions
Zimmer Biomet Holdings Inc -25.11%$ -25.111 millions
International Stem Cell Corporation-26.19%$ -26.190 millions
Jazz Pharmaceuticals Plc-26.51%$ -26.507 millions
Universal Health Services Inc -26.74%$ -26.740 millions
Brookdale Senior Living Inc -27.96%$ -27.956 millions
-29.00%$ -29.004 millions
Option Care Health Inc -29.95%$ -29.952 millions
Iqvia Holdings Inc -32.44%$ -32.445 millions
Abbott Laboratories-32.48%$ -32.482 millions
Bruker Corporation-36.55%$ -36.547 millions
Sotera Health Company-38.26%$ -38.257 millions
Puma Biotechnology Inc -38.50%$ -38.496 millions
Luna Innovations Inc-38.51%$ -38.514 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com